vs
Forian Inc.（FORA）与Verastem, Inc.（VSTM）财务数据对比。点击上方公司名可切换其他公司
Verastem, Inc.的季度营收约是Forian Inc.的1.4倍（$11.2M vs $8.0M），Forian Inc.净利率更高（-22.9% vs -876.3%，领先853.5%）
Forian Inc是一家专注于医疗健康领域的数据分析与技术服务商，提供SaaS模式的真实世界证据解决方案、临床决策支持工具及运营优化服务，客户覆盖生物制药企业、医疗机构及生命科学领域相关机构，助力提升诊疗效率、推动医学研究进展。
Verastem, Inc.以Verastem Oncology品牌开展业务，是一家总部位于美国马萨诸塞州波士顿的制药企业，专注于开发抗癌治疗药物，该公司成立于波士顿，同时是纳斯达克生物技术指数成分股之一。
FORA vs VSTM — 直观对比
营收规模更大
VSTM
是对方的1.4倍
$8.0M
净利率更高
FORA
高出853.5%
-876.3%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.0M | $11.2M |
| 净利润 | $-1.8M | $-98.5M |
| 毛利率 | 49.2% | — |
| 营业利润率 | -24.4% | -362.2% |
| 净利率 | -22.9% | -876.3% |
| 营收同比 | 37.0% | — |
| 净利润同比 | -1012.2% | -311.1% |
| 每股收益（稀释后） | $-0.06 | $-1.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORAVSTM
| Q4 25 | $8.0M | — | ||
| Q3 25 | $7.8M | $11.2M | ||
| Q2 25 | $7.5M | $2.1M | ||
| Q1 25 | $7.1M | — | ||
| Q4 24 | $5.8M | — | ||
| Q3 24 | $4.7M | $0 | ||
| Q2 24 | $4.8M | $10.0M | ||
| Q1 24 | $4.9M | — |
净利润FORAVSTM
| Q4 25 | $-1.8M | — | ||
| Q3 25 | $-151.2K | $-98.5M | ||
| Q2 25 | $224.8K | $-25.9M | ||
| Q1 25 | $-1.1M | — | ||
| Q4 24 | $199.7K | — | ||
| Q3 24 | $-204.9K | $-24.0M | ||
| Q2 24 | $-2.6M | $-8.3M | ||
| Q1 24 | $-1.2M | — |
毛利率FORAVSTM
| Q4 25 | 49.2% | — | ||
| Q3 25 | 51.6% | — | ||
| Q2 25 | 56.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 58.3% | — | ||
| Q3 24 | 70.1% | — | ||
| Q2 24 | 62.2% | — | ||
| Q1 24 | 65.1% | — |
营业利润率FORAVSTM
| Q4 25 | -24.4% | — | ||
| Q3 25 | -6.1% | -362.2% | ||
| Q2 25 | 0.6% | -2047.9% | ||
| Q1 25 | -19.8% | — | ||
| Q4 24 | -24.9% | — | ||
| Q3 24 | -17.0% | — | ||
| Q2 24 | -62.2% | -182.8% | ||
| Q1 24 | -36.3% | — |
净利率FORAVSTM
| Q4 25 | -22.9% | — | ||
| Q3 25 | -1.9% | -876.3% | ||
| Q2 25 | 3.0% | -1213.6% | ||
| Q1 25 | -16.0% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | -4.4% | — | ||
| Q2 24 | -53.4% | -82.6% | ||
| Q1 24 | -24.9% | — |
每股收益（稀释后）FORAVSTM
| Q4 25 | $-0.06 | — | ||
| Q3 25 | $0.00 | $-1.35 | ||
| Q2 25 | $0.01 | $-0.62 | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.01 | $-0.60 | ||
| Q2 24 | $-0.08 | $-0.31 | ||
| Q1 24 | $-0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $31.6M | $137.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $29.8M | $-15.5M |
| 总资产 | $44.1M | $176.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FORAVSTM
| Q4 25 | $31.6M | — | ||
| Q3 25 | $28.2M | $137.7M | ||
| Q2 25 | $35.6M | $164.3M | ||
| Q1 25 | $35.7M | — | ||
| Q4 24 | $35.1M | — | ||
| Q3 24 | $49.4M | $113.2M | ||
| Q2 24 | $48.0M | $83.4M | ||
| Q1 24 | $47.4M | — |
总债务FORAVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $40.5M | ||
| Q2 24 | — | $40.3M | ||
| Q1 24 | — | — |
股东权益FORAVSTM
| Q4 25 | $29.8M | — | ||
| Q3 25 | $31.1M | $-15.5M | ||
| Q2 25 | $30.9M | $36.1M | ||
| Q1 25 | $30.0M | — | ||
| Q4 24 | $30.1M | — | ||
| Q3 24 | $28.4M | $11.1M | ||
| Q2 24 | $27.2M | $18.9M | ||
| Q1 24 | $28.1M | — |
总资产FORAVSTM
| Q4 25 | $44.1M | — | ||
| Q3 25 | $41.3M | $176.9M | ||
| Q2 25 | $48.5M | $196.3M | ||
| Q1 25 | $48.6M | — | ||
| Q4 24 | $47.2M | — | ||
| Q3 24 | $57.5M | $126.4M | ||
| Q2 24 | $58.4M | $105.7M | ||
| Q1 24 | $57.5M | — |
负债/权益比FORAVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.66× | ||
| Q2 24 | — | 2.14× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.2M | $-36.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流FORAVSTM
| Q4 25 | $3.2M | — | ||
| Q3 25 | $-439.7K | $-36.2M | ||
| Q2 25 | $-344.5K | $-32.7M | ||
| Q1 25 | $448.2K | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $764.1K | $-23.8M | ||
| Q2 24 | $-23.1K | $-27.6M | ||
| Q1 24 | $-2.2M | — |
自由现金流FORAVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-27.6M | ||
| Q1 24 | — | — |
自由现金流率FORAVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -275.8% | ||
| Q1 24 | — | — |
资本支出强度FORAVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | — |
现金转化率FORAVSTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -1.53× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 8.76× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FORA
| Financial Services Revenues | $7.3M | 92% |
| Other | $669.0K | 8% |
VSTM
暂无分部数据
